{
 "as_of": "2026-11-04",
 "cmr": "hk-cm-kg/HKEX/01093",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# CSPC PHARMA (Main Board: 01093) — research page\n\nAs of 2026-11-04 · hk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is CSPC PHARMA, listed on the Main Board under ticker 01093 with ISIN HK1093012172. The LEI is not on the record. Its security type is Corporate. Segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 199 filings in the twelve months to 2026-11-04, across 128 filing days. The median gap between filing days is 2 days. The median gap for the Main Board is 9.0 days across 2472 issuers. The median filing count for the Main Board is 46.0. The latest filing is dated 2026-11-03, one day before the record date, and is of type announcement. The median latency for the Main Board is 2.0 days. Sector peer figures are not on the record.\n\n## Auditor\n\nThe auditor of record is Deloitte Touche Tohmatsu. Its location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record. The index does not carry a lifecycle type for this market. The issuer is listed and not halted.\n\n## Orderability\n\nThe outcome cannot be determined under rule version acm-68000/hk/suitability-sfc-code-of-conduct-paragraph-5-2/r1 as of 2026-11-04. The chapter's orderability section carries no client categories.\n\n## Coverage\n\nNo research houses were found on the investor-relations pages read.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. The live record began on 2026-09-12. Years 2021 through 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n6 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.hkex.com.hk/eng/services/trading/securities/securitieslists/ListOfSecurities.xlsx (identity.exchange)\n- https://mcp.hk-cm-kg.ai/events/HKEX/01093 (the disclosure lines)\n- https://www.hkex.com.hk/eng/stat/smstat/dayquot/d261104e.htm (the halt flag)\n- https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042803421.pdf (the auditor)\n- https://mcp.hk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.hk-cm-kg.ai/record/HKEX/01093 (the record)\n",
 "market": "HK",
 "node": "hk-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-12",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the HK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-04",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "annual report 2026-04-28 (HKEXnews), Corporate Information, read by Tavily page extraction",
    "read_date": "2026-11-04",
    "read_date_basis": "the record version as_of",
    "source": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042803421.pdf",
    "state": "confirmed",
    "value": "Deloitte Touche Tohmatsu"
   },
   "auditor_firm_id": {
    "market": "HK",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "HK",
    "state": "not_on_record"
   },
   "changes": {
    "market": "HK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "hk-cm-kg/HKEX/01093",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 2472,
     "median_cadence_gap_days": 9,
     "median_filings": 46,
     "median_latency_days": 2,
     "name": "Main Board"
    },
    "sector": {
     "market": "HK",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "agm_egm": 7,
    "announcement": 157,
    "annual_report": 1,
    "circular": 7,
    "constitutional_document": 1,
    "director_change": 5,
    "dividend": 2,
    "documents_on_display": 1,
    "esg_report": 1,
    "interim_report": 1,
    "monthly_return": 12,
    "results": 4
   },
   "cadence_median_gap_days": 2,
   "filing_days": 128,
   "filings": 199,
   "latency_days": 1,
   "latest": [
    {
     "category": null,
     "date": "2026-11-03",
     "source": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1103/2026110301858.pdf",
     "title": "VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6088 INJECTION FOR THE TREATMENT OF ADVANCED SOLID TUMOURS OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA",
     "type": "announcement"
    },
    {
     "category": null,
     "date": "2026-11-03",
     "source": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1103/2026110301838.pdf",
     "title": "VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL TRIAL OF SYH2072 TABLETS FOR THE TREATMENT OF UNCONTROLLED HYPERTENSION AND RESISTANT HYPERTENSION OFFICIALLY INITIATED AT THE FIRST CENTRE IN CHINA",
     "type": "announcement"
    },
    {
     "category": null,
     "date": "2026-11-02",
     "source": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1102/2026110203385.pdf",
     "title": "MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2026",
     "type": "monthly_return"
    },
    {
     "category": null,
     "date": "2026-11-02",
     "source": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1102/2026110203377.pdf",
     "title": "VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF PRUSOGLIPTIN TABLETS IN COMBINATION WITH DAPAGLIFLOZIN TABLETS AND METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS ACHIEVES POSITIVE TOPLINE RESULTS",
     "type": "announcement"
    },
    {
     "category": null,
     "date": "2026-11-02",
     "source": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1102/2026110203363.pdf",
     "title": "VOLUNTARY ANNOUNCEMENT - PHASE I/II CLINICAL TRIAL OF SYS6052 (RECOMBINANT HERPES ZOSTER VIRUS VACCINE (CHO CELLS)) OFFICIALLY INITIATED IN CHINA",
     "type": "announcement"
    }
   ],
   "latest_filing_date": "2026-11-03",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.hk-cm-kg.ai/events/HKEX/01093",
   "window": {
    "from": "2025-11-04",
    "to": "2026-11-04"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "HKEX List of Securities (ListOfSecurities.xlsx)",
    "read_date": "2026-11-04",
    "read_date_basis": "the record version as_of",
    "source": "https://www.hkex.com.hk/eng/services/trading/securities/securitieslists/ListOfSecurities.xlsx",
    "state": "sourced",
    "value": "Main Board"
   },
   "isin": {
    "read_by": "HKEX List of Securities (ListOfSecurities.xlsx)",
    "read_date": "2026-11-04",
    "read_date_basis": "the record version as_of",
    "source": "https://www.hkex.com.hk/eng/services/trading/securities/securitieslists/ListOfSecurities.xlsx",
    "state": "sourced",
    "value": "HK1093012172"
   },
   "jurisdiction": {
    "market": "HK",
    "reason": "no LEI record",
    "state": "not_on_record"
   },
   "lei": {
    "market": "HK",
    "reason": "ISIN not in the GLEIF mapping file (no name route on this node: no search layer by order)",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "HKEX List of Securities (ListOfSecurities.xlsx)",
    "read_date": "2026-11-04",
    "read_date_basis": "the record version as_of",
    "source": "https://www.hkex.com.hk/eng/services/trading/securities/securitieslists/ListOfSecurities.xlsx",
    "state": "sourced",
    "value": "CSPC PHARMA"
   },
   "sector": {
    "market": "HK",
    "reason": "HKEX publishes the industry classification per issuer on its website pages, not in the List of Securities (no page reads by order)",
    "state": "not_on_record"
   },
   "security_type": {
    "read_by": "HKEX List of Securities (ListOfSecurities.xlsx)",
    "read_date": "2026-11-04",
    "read_date_basis": "the record version as_of",
    "source": "https://www.hkex.com.hk/eng/services/trading/securities/securitieslists/ListOfSecurities.xlsx",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "HK",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "HKEX List of Securities (ListOfSecurities.xlsx)",
    "read_date": "2026-11-04",
    "read_date_basis": "the record version as_of",
    "source": "https://www.hkex.com.hk/eng/services/trading/securities/securitieslists/ListOfSecurities.xlsx",
    "state": "sourced",
    "value": "01093"
   },
   "website": {
    "market": "HK",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "HK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "HK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "HK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "HK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "HK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "HK",
  "node": "hk-cm-kg",
  "numbers_hash": "sha256:e483ac4737a66bbcb4a272af263b797ba4c61b4b1036bf73e7759ae3b98f9a0c",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.hk-cm-kg.ai/book/aio.json",
    "door": "https://mcp.hk-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/hk/suitability-sfc-code-of-conduct-paragraph-5-2/r1",
   "section": "hk.aio.v6"
  },
  "record": {
   "as_of": "2026-11-04",
   "url": "https://mcp.hk-cm-kg.ai/record/HKEX/01093",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-04",
   "source": "https://www.hkex.com.hk/eng/stat/smstat/dayquot/d261104e.htm",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:e483ac4737a66bbcb4a272af263b797ba4c61b4b1036bf73e7759ae3b98f9a0c",
 "path": "/hk/HKEX/01093",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is CSPC PHARMA, listed on the Main Board under ticker 01093 with ISIN HK1093012172. The LEI is not on the record. Its security type is Corporate. Segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 199 filings in the twelve months to 2026-11-04, across 128 filing days. The median gap between filing days is 2 days. The median gap for the Main Board is 9.0 days across 2472 issuers. The median filing count for the Main Board is 46.0. The latest filing is dated 2026-11-03, one day before the record date, and is of type announcement. The median latency for the Main Board is 2.0 days. Sector peer figures are not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is Deloitte Touche Tohmatsu. Its location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record. The index does not carry a lifecycle type for this market. The issuer is listed and not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome cannot be determined under rule version acm-68000/hk/suitability-sfc-code-of-conduct-paragraph-5-2/r1 as of 2026-11-04. The chapter's orderability section carries no client categories.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the investor-relations pages read.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. The live record began on 2026-09-12. Years 2021 through 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "6 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.hkex.com.hk/eng/services/trading/securities/securitieslists/ListOfSecurities.xlsx"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.hk-cm-kg.ai/events/HKEX/01093"
  },
  {
   "for": "the halt flag",
   "source": "https://www.hkex.com.hk/eng/stat/smstat/dayquot/d261104e.htm"
  },
  {
   "for": "the auditor",
   "source": "https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042803421.pdf"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.hk-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.hk-cm-kg.ai/record/HKEX/01093"
  }
 ],
 "title": "CSPC PHARMA (01093) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}